Ventyx Biosciences, Inc. Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ventyx Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • Ventyx Biosciences, Inc. Return On Equity for the quarter ending June 30, 2024 was -61.4 %, a 39.8% decline year-over-year.
  • Ventyx Biosciences, Inc. annual Return On Equity for 2023 was -62.9 %, a 79.8% decline from 2022.
  • Ventyx Biosciences, Inc. annual Return On Equity for 2022 was -35 %, a 94.6% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -61.4 -17.5 -39.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -66.3 -29.4 -79.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -62.9 -27.9 -79.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -54.3 -23 -73.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -44 -1.69 -4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -36.9 +36.6 +49.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -35 +609 +94.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -31.2 Jul 1, 2022 Sep 30, 2022
Q2 2022 -42.3 Apr 1, 2022 Jun 30, 2022
Q1 2022 -73.5 Jan 1, 2022 Mar 31, 2022
Q4 2021 -644 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.